vs
Side-by-side financial comparison of HWH International Inc. (HWH) and Vir Biotechnology, Inc. (VIR). Click either name above to swap in a different company.
Vir Biotechnology, Inc. is the larger business by last-quarter revenue ($240.0K vs $206.8K, roughly 1.2× HWH International Inc.). HWH International Inc. runs the higher net margin — -140.7% vs -67975.4%, a 67834.7% gap on every dollar of revenue. On growth, HWH International Inc. posted the faster year-over-year revenue change (-40.2% vs -89.9%). HWH International Inc. produced more free cash flow last quarter ($-217.9K vs $-167.9M).
HWH International Inc operates in the global luxury hospitality and lifestyle services industry, providing premium travel membership programs, curated high-end travel experiences, and exclusive access to luxury resorts, fine dining venues, and premium leisure facilities. Its key markets include North America, Asia Pacific, and Europe, serving high-net-worth individuals and corporate clients.
Vir Biotechnology, Inc. is a clinical-stage immunology company focused on developing innovative therapies and vaccines to address serious infectious diseases including COVID-19, hepatitis B, HIV, and influenza. It operates primarily in the global biopharmaceutical market, collaborating with leading industry partners to advance its pipeline of targeted immune-based solutions for patient populations worldwide.
HWH vs VIR — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $206.8K | $240.0K |
| Net Profit | $-291.0K | $-163.1M |
| Gross Margin | 59.8% | — |
| Operating Margin | -142.7% | -72267.9% |
| Net Margin | -140.7% | -67975.4% |
| Revenue YoY | -40.2% | -89.9% |
| Net Profit YoY | 46.9% | 23.7% |
| EPS (diluted) | — | $-1.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $206.8K | $240.0K | ||
| Q2 25 | $310.4K | $1.2M | ||
| Q1 25 | — | $3.0M | ||
| Q4 24 | $287.1K | $12.4M | ||
| Q3 24 | $345.5K | $2.4M | ||
| Q2 24 | $334.9K | $3.1M | ||
| Q1 24 | $286.1K | $56.4M | ||
| Q4 23 | — | $16.8M |
| Q3 25 | $-291.0K | $-163.1M | ||
| Q2 25 | $83.4K | $-111.0M | ||
| Q1 25 | — | $-121.0M | ||
| Q4 24 | $-476.7K | — | ||
| Q3 24 | $-548.5K | $-213.7M | ||
| Q2 24 | $-387.9K | $-138.4M | ||
| Q1 24 | $-1.3M | $-65.3M | ||
| Q4 23 | — | — |
| Q3 25 | 59.8% | — | ||
| Q2 25 | 48.0% | 99.1% | ||
| Q1 25 | — | — | ||
| Q4 24 | 39.6% | — | ||
| Q3 24 | 46.3% | 97.9% | ||
| Q2 24 | 49.2% | 98.3% | ||
| Q1 24 | 57.1% | 99.9% | ||
| Q4 23 | — | 95.2% |
| Q3 25 | -142.7% | -72267.9% | ||
| Q2 25 | 24.5% | -9754.3% | ||
| Q1 25 | — | -4602.5% | ||
| Q4 24 | -170.2% | — | ||
| Q3 24 | -155.5% | -9718.7% | ||
| Q2 24 | -120.5% | -5158.7% | ||
| Q1 24 | -467.1% | -142.0% | ||
| Q4 23 | — | — |
| Q3 25 | -140.7% | -67975.4% | ||
| Q2 25 | 26.9% | -9139.9% | ||
| Q1 25 | — | -3989.6% | ||
| Q4 24 | -166.1% | — | ||
| Q3 24 | -158.7% | -8979.7% | ||
| Q2 24 | -115.8% | -4500.1% | ||
| Q1 24 | -467.2% | -115.8% | ||
| Q4 23 | — | — |
| Q3 25 | — | $-1.17 | ||
| Q2 25 | — | $-0.80 | ||
| Q1 25 | — | $-0.88 | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-1.56 | ||
| Q2 24 | — | $-1.02 | ||
| Q1 24 | — | $-0.48 | ||
| Q4 23 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.9M | $497.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.8M | $796.1M |
| Total Assets | $5.2M | $1.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $2.9M | $497.8M | ||
| Q2 25 | $3.7M | $598.7M | ||
| Q1 25 | — | $790.9M | ||
| Q4 24 | $4.4M | $901.0M | ||
| Q3 24 | $836.3K | $909.0M | ||
| Q2 24 | $958.9K | $1.1B | ||
| Q1 24 | $1.1M | $1.1B | ||
| Q4 23 | — | $1.5B |
| Q3 25 | $2.8M | $796.1M | ||
| Q2 25 | $3.2M | $947.5M | ||
| Q1 25 | — | $1.0B | ||
| Q4 24 | $2.8M | $1.2B | ||
| Q3 24 | $-374.9K | $1.2B | ||
| Q2 24 | $-3.6M | $1.4B | ||
| Q1 24 | $-3.1M | $1.5B | ||
| Q4 23 | — | $1.6B |
| Q3 25 | $5.2M | $1.0B | ||
| Q2 25 | $10.6M | $1.2B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | $6.4M | $1.4B | ||
| Q3 24 | $2.9M | $1.5B | ||
| Q2 24 | $3.1M | $1.7B | ||
| Q1 24 | $2.6M | $1.8B | ||
| Q4 23 | — | $1.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-199.9K | $-167.6M |
| Free Cash FlowOCF − Capex | $-217.9K | $-167.9M |
| FCF MarginFCF / Revenue | -105.4% | -69952.9% |
| Capex IntensityCapex / Revenue | 8.7% | 132.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-824.0M |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $-199.9K | $-167.6M | ||
| Q2 25 | $26.9K | $-120.2M | ||
| Q1 25 | — | $-78.1M | ||
| Q4 24 | $-415.2K | $-446.4M | ||
| Q3 24 | $-275.0K | $-171.5M | ||
| Q2 24 | $-490.8K | $-77.8M | ||
| Q1 24 | $-638.2K | $-109.4M | ||
| Q4 23 | — | $-778.8M |
| Q3 25 | $-217.9K | $-167.9M | ||
| Q2 25 | — | $-122.8M | ||
| Q1 25 | — | $-79.7M | ||
| Q4 24 | $-415.5K | $-453.7M | ||
| Q3 24 | $-277.1K | $-174.2M | ||
| Q2 24 | $-516.8K | $-78.5M | ||
| Q1 24 | $-640.3K | $-111.3M | ||
| Q4 23 | — | $-800.4M |
| Q3 25 | -105.4% | -69952.9% | ||
| Q2 25 | — | -10111.8% | ||
| Q1 25 | — | -2630.1% | ||
| Q4 24 | -144.7% | -3666.2% | ||
| Q3 24 | -80.2% | -7321.3% | ||
| Q2 24 | -154.3% | -2553.3% | ||
| Q1 24 | -223.8% | -197.4% | ||
| Q4 23 | — | -4767.7% |
| Q3 25 | 8.7% | 132.1% | ||
| Q2 25 | — | 209.1% | ||
| Q1 25 | — | 53.7% | ||
| Q4 24 | 0.1% | 59.0% | ||
| Q3 24 | 0.6% | 116.3% | ||
| Q2 24 | 7.7% | 21.7% | ||
| Q1 24 | 0.7% | 3.3% | ||
| Q4 23 | — | 128.5% |
| Q3 25 | — | — | ||
| Q2 25 | 0.32× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
